USPTO serial 75526970
JOURNEY TO I.C.R.A.
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- TAYLOR, DAVID T
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with JOURNEY TO I.C.R.A.?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
New Brunswick, NJ
New Brunswick, NJ
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Richard F. Biribauer
RICHARD F BIRIBAUER JOHNSON & JOHNSON1 JOHNSON AND JOHNSON PLZNEW BRUNSWICK, NJ 08933-0001UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | VIRTUAL REALITY SIMULATOR IN THE FIELD OF CANCER THERAPY, COMPRISED OF COMPUTER HARDWARE, COMPUTER SOFTWARE AND COMPUTER PERIPHERALS, FOR SIMULATING THE DEBILITATING EFFECTS OF CANCER-RELATED ANEMIA AND ITS RESULTING FATIGUE EXPERIENCED BY PATIENTS | ACTIVE | Nov 7, 2000 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 17, 2002 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 30, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 3, 2001 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 30, 2001 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Aug 27, 2001 | IUAF | USE AMENDMENT FILED | — |
| May 23, 2001 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 14, 2001 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 25, 2001 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 15, 2000 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 16, 2000 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 22, 2000 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 21, 2000 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 13, 1999 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 16, 1999 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 13, 1999 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 18, 1999 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 1, 1999 | DOCK | ASSIGNED TO EXAMINER | — |